Association of Co-Morbidities with Prescribing Patterns and Cost Savings: Olanzapine versus Risperidone for Schizophrenia

Author： Yu Wei Ren Xinhua S. Lee Austin F. Herz Lawrence Huang Yu-Hui Kazis Lewis E.

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.24, Iss.12, 2006-01, pp. : 1233-1248

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effectiveness and Cost of Risperidone and Olanzapine for Schizophrenia: A Systematic Review

By Hargreaves William A.

CNS Drugs, Vol. 19, Iss. 5, 2005-01 ,pp. : 393-410

Adis International

Access to resources Recommend Favorite

Olanzapine and risperidone on a par in schizophrenia

Inpharma, Vol. 1, Iss. 1240, 2000-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Olanzapine and risperidone on a par in schizophrenia

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 265, 2000-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Olanzapine versus Risperidone: A Prospective Comparison of Clinical and Economic Outcomes in Schizophrenia

By Edgell E.T.

PharmacoEconomics, Vol. 18, Iss. 6, 2000-12 ,pp. : 567-579

Adis International

Access to resources Recommend Favorite

Medication Treatment Patterns following Initiation on Olanzapine versus Risperidone: A Retrospective Analysis

By Zhao Z. Tunis S.L. Lage M.J.

Clinical Drug Investigation, Vol. 22, Iss. 11, 2002-01 ,pp. : 741-749

Adis International

Access to resources Recommend Favorite